Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 6451082, 1 page

Corrigendum to “Inositol(s) from Bench to Bedside in Endocrinology and Gynecology”

1Department of Medical Sciences, IPUS-Institute of Higher Education, Chiasso, Switzerland
2Department of Medicine and Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA, USA
3Clinic of Endocrinology, Alexandrovska University Hospital, Medical University, Sofia, Bulgaria
4IAKENTRO, Infertility Treatment Center, Thessaloniki, Greece
5Mother-Infant Department, University of Modena and Reggio Emilia, Modena, Italy

Correspondence should be addressed to Vittorio Unfer; moc.liamg@refnuv

Received 20 November 2017; Accepted 27 November 2017; Published 28 December 2017

Copyright © 2017 Vittorio Unfer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the Editorial titled “Inositol(s) from Bench to Bedside in Endocrinology and Gynecology” [1], a “Conflicts of Interest” section should have been added as follows:

Conflicts of Interest

Vittorio Unfer, the lead guest editor of the special issue, is an employee of LO.LI. PHARMA SRL. This company markets products containing inositols. John E. Nestler has received travel expenses from LO.LI. PHARMA and SUN Pharmaceuticals. Zdravko A. Kamenov has received travel expenses from LO.LI PHARMA. Fabio Facchinetti has received travel expenses from LO.LI. PHARMA, SUN Pharmaceuticals, and Alkem Laboratories. Nikos Prapas has no interests to declare.


  1. V. Unfer, J. E. Nestler, Z. A. Kamenov, N. Prapas, and F. Facchinetti, “Inositol(s) from bench to bedside in endocrinology and gynecology,” International Journal of Endocrinology, vol. 2017, Article ID 8515703, 2 pages, 2017. View at Publisher · View at Google Scholar